The positive rate of SPARC expression in NSCLC with lymph node metastasis was significantly higher than that without lymph node metastasis (81.3% vs 58.5%, P < 0.05). This evidence concerns the gene SPARC and metastatic malignant neoplasm in the lymph nodes.